ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,191Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 2061

$1.49M Total Retail Price of All Prescriptions

Rank: 31 out of 2061

707 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 707 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 707 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 21,864 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LEVOTHYROXINE SODIUM 1,034 872 1 3
AMLODIPINE BESYLATE 875 720 2 4
METOPROLOL TARTRATE 863 774 3 7
OMEPRAZOLE 835 716 4 5
SIMVASTATIN 775 666 5 1
POTASSIUM CHLORIDE 734 668 6 16
FUROSEMIDE 672 606 7 6
HYDROCODONE-ACETAMINOPHEN 541 384 S3 8 10
WARFARIN SODIUM 522 462 9 11
METFORMIN HCL 513 437 10 9
DOXYCYCLINE HYCLATE 400 304 11 98
PREDNISONE 386 319 12 32
DONEPEZIL HCL 365 357 13 24
JANTOVEN 360 311 14 93
ATENOLOL 321 279 15 13
LOSARTAN POTASSIUM 318 301 16 17
LISINOPRIL 294 278 17 2
CITALOPRAM HBR 291 250 18 20
METHYLPREDNISOLONE 273 215 19 101
BUMETANIDE 266 243 20 136
GABAPENTIN 252 201 21 15
HYDRALAZINE HCL 251 214 22 69
DIOVAN 245 211 23 41
TAMSULOSIN HCL 244 240 24 30
ISOSORBIDE MONONITRATE ER 237 213 25 42
NEXIUM 234 177 26 26
CIPROFLOXACIN HCL 229 205 27 54
METOPROLOL SUCCINATE 221 198 28 19
DIGOXIN 217 204 29 56
PRAVASTATIN SODIUM 217 179 29 14
CARVEDILOL 195 166 31 22
FAMOTIDINE 190 156 32 67
NAMENDA 188 188 33 37
TRIAMTERENE-HCTZ 172 139 34 38
SINGULAIR 168 138 35 88
GLIPIZIDE 164 148 36 55
NOVOLIN R 159 140 37 129
SUCRALFATE 155 97 38 151
CLONIDINE HCL 152 123 39 52
FINASTERIDE 147 143 40 86
CLOPIDOGREL 143 129 41 29
LANTUS 142 114 42 48
CARBIDOPA-LEVODOPA 139 136 43 97
GLIMEPIRIDE 138 114 44 33
FLUTICASONE PROPIONATE 137 94 45 43
SERTRALINE HCL 135 122 46 21
AMOX TR-POTASSIUM CLAVULANATE 134 71 47 113
TRIAMCINOLONE ACETONIDE 134 117 47 172
ATORVASTATIN CALCIUM 133 120 49 8
CEPHALEXIN 129 107 50 112
GLIPIZIDE ER 129 106 50 133
KLOR-CON M20 128 110 52 47
OXYCODONE-ACETAMINOPHEN 123 30 S2 53 36
PANTOPRAZOLE SODIUM 123 86 53 45
MONTELUKAST SODIUM 120 96 55 176
KLOR-CON M10 114 100 56 125
GLIPIZIDE XL 114 80 56 197
ALLOPURINOL 112 99 58 28
ALBUTEROL SULFATE 111 96 59 104
PLAVIX 109 97 60 49
LOVASTATIN 107 92 61 35
POLYETHYLENE GLYCOL 3350 106 82 62 64
SPIRONOLACTONE 104 80 63 62
SODIUM CHLORIDE 102 91 64 192
MIRTAZAPINE 101 86 65 46
CRESTOR 100 93 66 31
NYSTATIN 97 85 67 148
TORSEMIDE 97 85 67 126
ADVAIR DISKUS 97 79 67 57
MECLIZINE HCL 96 91 70 142
LEVETIRACETAM 91 79 71 102
RENVELA 85 50 72 288
AMOXICILLIN 84 70 73 121
ROPINIROLE HCL 81 65 74 92
DOXAZOSIN MESYLATE 80 73 75 81
RISPERIDONE 79 70 76 66
ENOXAPARIN SODIUM 79 67 76 267
AZITHROMYCIN 78 71 78 34
IPRATROPIUM-ALBUTEROL 78 62 78 117
METOCLOPRAMIDE HCL 77 41 80 138
VERAPAMIL ER 76 41 81 100
INSULIN SYRINGE 73 54 82 105
TRAZODONE HCL 71 51 83 39
HYDROCHLOROTHIAZIDE 71 68 83 12
NIFEDIPINE ER 71 71 83 134
AMITRIPTYLINE HCL 70 51 R 86 89
AMLODIPINE BESYLATE-BENAZEPRIL 70 63 86 79
LOPERAMIDE 70 61 86 283
OXCARBAZEPINE 69 39 89 244
PROAIR HFA 68 53 90 40
DETROL LA 68 41 90 264
LOSARTAN-HYDROCHLOROTHIAZIDE 65 60 92 50
HUMULIN 70-30 64 52 93 271
CEFTRIAXONE 63 56 94 228
OXYBUTYNIN CHLORIDE ER 62 62 95 80
DILTIAZEM 24HR ER 62 62 95 108
ALENDRONATE SODIUM 62 59 95 25
ZOLPIDEM TARTRATE 60 47 98 23
CYMBALTA 60 47 98 59
QUINAPRIL HCL 58 48 100 127
FENTANYL 57 29 S2 101 84
JANUVIA 57 57 101 51
MEGESTROL ACETATE 57 53 R 101 198
ESCITALOPRAM OXALATE 54 54 104 77
LACTULOSE 53 36 105 131
LANSOPRAZOLE 53 37 105 139
TRAMADOL HCL 53 43 105 18
AMIODARONE HCL 53 41 105 168
MIDODRINE HCL 53 43 105 290
NOVOLOG MIX 70-30 53 51 105 250
LIDODERM 52 47 111 106
VENLAFAXINE HCL ER 52 34 111 109
VITAMIN D2 51 47 113 146
FLUCONAZOLE 50 38 114 200
GLYBURIDE 50 50 R 114 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 10, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.